5th Jun 2023 7:00 am |
RNS |
ANGLE announces senior management appointments |
25th May 2023 7:00 am |
RNS |
Pharma services contract with Artios Pharma |
22nd May 2023 7:00 am |
RNS |
Board change - appointment of new Chairman |
21st Apr 2023 12:04 pm |
RNS |
ANGLE presentation via Investor Meet Company |
21st Apr 2023 7:00 am |
RNS |
Results for the year ended 31 December 2022 |
19th Apr 2023 7:00 am |
RNS |
ANGLE announces partnership with BioView |
17th Apr 2023 7:00 am |
RNS |
ANGLE Parsortix poster presented at AACR 2023 |
13th Apr 2023 7:00 am |
RNS |
Pharma Services Contract with Crescendo Biologics |
3rd Apr 2023 7:00 am |
RNS |
Notice of Preliminary Results and Webcast |
10th Mar 2023 7:00 am |
RNS |
Issue of LTIP Options and Share Options |
9th Mar 2023 3:03 pm |
RNS |
Holding(s) in Company |
9th Feb 2023 2:44 pm |
RNS |
Director/PDMR shareholding |
19th Jan 2023 7:00 am |
RNS |
Appointment of Non-Executive Director |
11th Jan 2023 5:20 pm |
RNS |
Holding(s) in Company |
10th Jan 2023 6:20 pm |
RNS |
Holding(s) in Company |
6th Jan 2023 11:05 am |
RNS |
Second Price Monitoring Extn |
6th Jan 2023 11:00 am |
RNS |
Price Monitoring Extension |
5th Jan 2023 9:05 am |
RNS |
Second Price Monitoring Extn |
5th Jan 2023 9:00 am |
RNS |
Price Monitoring Extension |
5th Jan 2023 7:01 am |
RNS |
Appointment of Non-Executive Director |
5th Jan 2023 7:00 am |
RNS |
Business Update |
12th Dec 2022 7:00 am |
RNS |
Two Parsortix posters presented at SABCS |
2nd Dec 2022 5:30 pm |
RNS |
Issue of Equity |
2nd Nov 2022 7:00 am |
RNS |
Multiple downstream analysis techniques for CTCs |
1st Nov 2022 4:41 pm |
RNS |
Second Price Monitoring Extn |
1st Nov 2022 4:35 pm |
RNS |
Price Monitoring Extension |
24th Oct 2022 7:00 am |
RNS |
Parsortix poster presented at ISLB meeting |
21st Oct 2022 6:15 pm |
RNS |
Issue of Equity |
18th Oct 2022 7:00 am |
RNS |
Streamlining of operations to increase cash runway |
17th Oct 2022 2:23 pm |
RNS |
TR-1: Notification of major holdings |
12th Oct 2022 7:00 am |
RNS |
First regional distribution agreement |
30th Sep 2022 5:30 pm |
RNS |
Issue of Equity |
30th Sep 2022 5:30 pm |
RNS |
Holding(s) in Company |
29th Sep 2022 7:00 am |
RNS |
Interim Results |
29th Sep 2022 7:00 am |
RNS |
Positive headline results from ovarian study |
28th Sep 2022 7:00 am |
RNS |
Study using Parsortix in head and neck cancer |
13th Sep 2022 7:00 am |
RNS |
New poster presented at ASCP Meeting |
12th Sep 2022 7:30 am |
RNS |
Novel assay predicts malignancy in pelvic mass |
1st Sep 2022 7:00 am |
RNS |
Notice of Interim Results and Webcast |
28th Jul 2022 7:00 am |
RNS |
Novel insight into metastasis in NSCLC patients |